GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » New Ray Medicine International Holding Ltd (HKSE:06108) » Definitions » Price-to-Tangible-Book

New Ray Medicine International Holding (HKSE:06108) Price-to-Tangible-Book : 0.15 (As of May. 25, 2025)


View and export this data going back to 2013. Start your Free Trial

What is New Ray Medicine International Holding Price-to-Tangible-Book?

As of today (2025-05-25), New Ray Medicine International Holding's share price is HK$0.042. New Ray Medicine International Holding's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was HK$0.27. Hence, New Ray Medicine International Holding's Price to Tangible Book Ratio of today is 0.15.

The historical rank and industry rank for New Ray Medicine International Holding's Price-to-Tangible-Book or its related term are showing as below:

HKSE:06108' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.15   Med: 0.86   Max: 1.26
Current: 0.16

During the past 13 years, New Ray Medicine International Holding's highest Price to Tangible Book Ratio was 1.26. The lowest was 0.15. And the median was 0.86.

HKSE:06108's Price-to-Tangible-Book is ranked better than
99.6% of 506 companies
in the Healthcare Providers & Services industry
Industry Median: 2.735 vs HKSE:06108: 0.16

A closely related ratio is called PB Ratio. As of today, New Ray Medicine International Holding's share price is HK$0.042. New Ray Medicine International Holding's Book Value per Sharefor the quarter that ended in Dec. 2024 was HK$0.28. Hence, New Ray Medicine International Holding's P/B Ratio of today is 0.15.


New Ray Medicine International Holding Price-to-Tangible-Book Historical Data

The historical data trend for New Ray Medicine International Holding's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Ray Medicine International Holding Price-to-Tangible-Book Chart

New Ray Medicine International Holding Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.26 1.19 0.32 0.18 0.17

New Ray Medicine International Holding Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.21 0.18 0.15 0.17

Competitive Comparison of New Ray Medicine International Holding's Price-to-Tangible-Book

For the Pharmaceutical Retailers subindustry, New Ray Medicine International Holding's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Ray Medicine International Holding's Price-to-Tangible-Book Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, New Ray Medicine International Holding's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where New Ray Medicine International Holding's Price-to-Tangible-Book falls into.


;
;

New Ray Medicine International Holding Price-to-Tangible-Book Calculation

New Ray Medicine International Holding's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2024 )
=0.042/0.272
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


New Ray Medicine International Holding Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of New Ray Medicine International Holding's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


New Ray Medicine International Holding Business Description

Traded in Other Exchanges
N/A
Address
19 Dangui Road, B-C, 37th Floor, Dikai International Center, Hangzhou, CHN
New Ray Medicine International Holding Ltd is engaged in the trading and distribution of pharmaceutical products in the People's Republic of China. The company's segments include the Distribution and trading of pharmaceutical products and the Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs and generate a majority of revenue for the company.
Executives
Dai Xiaosong
Eagle Amber Holdings Limited
Chu Xueping 2201 Interest of corporation controlled by you
Qian Shenglei 2101 Beneficial owner
Zhang Jiang 2201 Interest of corporation controlled by you
Yang Fang 2202 Interest of your spouse
Zhou Ling 2101 Beneficial owner

New Ray Medicine International Holding Headlines

No Headlines